MedPath

TARO-CARBAMAZEPINE

TARO-CARBAMAZEPINE

Approved
DIN Number

02367394

Drug Class

Human

Market Date

Oct 7, 2011

Company
HC

Taro Pharmaceuticals Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02367394
AIG Number0108674002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AF01 CARBAMAZEPINE
Product Specifications
Dosage FormSuspension
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

CARBAMAZEPINEActive
Strength: 100 MG / 5 ML
Monograph: CARBAMAZEPINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.